Results 161 to 170 of about 12,390 (209)

Stereotactic Prostate Cancer Ablative Re‐Irradiation: A Systematic Review and Meta‐Analysis (SPARE)

The Prostate, EarlyView.
ABSTRACT Background Stereotactic ablative radiotherapy (SABR) is emerging as an alternative treatment for patients with locally recurrent prostate cancer after previous radiation. This approach allows for precise target coverage while limiting toxicity to surrounding organs.
Andre G. Gouveia, Jody Tao, Gregory Pond, Kevin Dong, Allison Ye, Arthur A. Rosa, Daniel M. Palhares, Conrad J. Q. Villafuerte, Paola Anselmo, Fabio Y. Moraes, Fabio Arcidiacono, Robert Olson, Theodoros Tsakiridis   +12 more
wiley   +1 more source

Human Prostate Cell Lines: Derivation, Molecular Characteristics and Appropriate Use

The Prostate, EarlyView.
ABSTRACT Background Research on prostate cancer and benign prostatic hyperplasia depends on a small number of immortalized human cell lines established between 1977 and 2001, most of them from advanced metastatic disease. The cell lines differ from one another in androgen receptor status, prostate‐specific antigen secretion, p53 status, karyotype and ...
Hamza Abohamra, Keenau Mark Pearce
wiley   +1 more source

Dynamic control of carbon-ion radiation dose distribution amid respiratory motion challenges: A review of prediction research using geant4 and deep learning physics-constrained models. [PDF]

J Appl Clin Med Phys
Ding J, Li P, Yeong CH.
europepmc   +1 more source

Real‐World HRR Testing Pathways and Patterns of Detected Alterations in Prostate Cancer From the Multinational ARON‐3 Study

The Prostate, EarlyView.
ABSTRACT Background Homologous recombination repair (HRR) testing is increasingly relevant in prostate cancer because it identifies patients who may benefit from biomarker‐guided treatment strategies, including poly(ADP‐ribose) polymerase inhibitors (PARPi).
Lorena Incorvaia, Veronica Mollica, Ondřej Fiala, Kazutoshi Fujita, Yüksel Ürün, Bohuslav Melichar, Javier Molina‐Cerrillo, Teresa Alonso‐Gordoa, Umberto Basso, Maria T. Bourlon, Emmanuel Seront, Ugo De Giorgi, Maria José Juan Fita, Pasquale Rescigno, Tarek Taha, Fernando C. Maluf, Alexandr Poprach, Simona De Summa, Tomas Buchler, Luca Galli, Jindrich Kopecky, Gaetano Aurilio, Jakub Kucharz, Carlo Messina, Gabriel Berlingieri Polho, Sarah Scagliarini, Francesco Grillone, Diogo Assed Bastos, Luigi Formisano, Gian Paolo Spinelli, Alessandra Mosca, Alessandro Rizzo, Aristotelis Bamias, Fernando Sabino Marques Monteiro, Andrey Soares, Francesco Massari, Andrew J. Armstrong, Matteo Santoni   +37 more
wiley   +1 more source

Ablative ultra-hypofractionated radiotherapy with surgical GI exclusion as a "functional spacer" for pancreatic cancer: a phase I safety and feasibility study. [PDF]

BMC Cancer
Di Y, Xia T, Wang Y, Ren G.
europepmc   +1 more source

Context‐Dependent Radioenhancement by Platinum Nanoparticles Under Conventional and Ultra‐High Dose‐Rate “FLASH” Radiotherapy

Small, EarlyView.
Overview of the experimental workflow and main findings of the study investigating Pt‐NPs‐mediated radioenhancement under conventional 134 dose‐rate (CONV) and ultrahigh dose‐rate (UHDR) 9 MeV electron irradiation. Pt‐NP distribution and uptake were characterized in 4T1 spheroids and syngeneic tumor models.
Cathyanne Schott, Foutina Feghali, Marine Gerbé de Thoré, Amina Joudat, Lydia Meziani, Aashini Rajpal, Winchygn Liu, Tudor Manoliu, Farah Savina, Sandrine Lacombe, Eric Deutsch, Julie Colnot, Charlotte Robert, Erika Porcel, Pauline Maury   +14 more
wiley   +1 more source

Correction: Influence factor and mechanism of FLASH effect

Frontiers in Oncology
Tingyu Feng, Tingyu Feng, Tianyang He, Wentao Ye, Lisha Xiang   +4 more
doaj   +1 more source

Use of apertures in single-energy pristine Bragg peak FLASH radiotherapy. [PDF]

J Appl Clin Med Phys
Ma Y, Selvaraj B, Zhao X, Cheng C, Chen CC, Diao L, Wang Y, Wang Z, Pei Y, Liu L, Yan X, Durkee B, Simone CB, Lin H, Mou X, Kang M.   +15 more
europepmc   +1 more source

Multifunctional Nanoreactor Based on Catalyst Surface Engineering Combines pH‐Adaptive Catalysis With Tumor Microenvironment Modulation for Synergistic Chemodynamic‐Chemotherapy

Small, EarlyView.
A folate‐targeted Fe2O3@MoS2‐Pt/FA nanoreactor creates a localized acidic catalytic interface while simultaneously elevating intracellular H2O2 and consuming GSH. This dual regulation of reaction conditions and substrate availability markedly enhances Fenton‐driven chemodynamic therapy and synergistic chemotherapy for efficient tumor eradication ...
Yuchen Liu, Shan Lin, Pengyuan Song, Xianan Li, Jingwen Wang, Yang Zhang, Mingli Cai, Kang Fu, Ziyue Xu, Qianqian Zhao, Long Zhang, Jie Shen, Shibo Wang, Xiangdong Kong, Pu Chen   +14 more
wiley   +1 more source